标签
多塔
化学
体外
组合化学
螯合作用
生物化学
有机化学
作者
Aurélie Maisonial‐Besset,Tiffany Witkowski,Mercédès Quintana,Sophie Besse,Vincent Gaumet,Axel Cordonnier,Cyrille Alliot,Aurélien Vidal,Caroline Denevault‐Sabourin,Sébastien Tarrit,Sophie Lévesque,Elisabeth Miot-Noirault,Jean‐Michel Chezal
出处
期刊:Molecules
[Multidisciplinary Digital Publishing Institute]
日期:2022-12-22
卷期号:28 (1): 75-75
被引量:7
标识
DOI:10.3390/molecules28010075
摘要
The development of 64Cu-based immuno-PET radiotracers requires the use of copper-specific bifunctional chelators (BFCs) that contain functional groups allowing both convenient bioconjugation and stable copper complexes to limit in vivo bioreduction, transmetallation and/or transchelation. The excellent in vivo kinetic inertness of the pentaazamacrocyclic [64Cu]Cu-15-5 complex prompted us to investigate its potential for the 64Cu-labelling of monoclonal antibodies (mAbs), compared with the well-known NODAGA and DOTA chelators. To this end, three NODAGA, DOTA and 15-5-derived BFCs, containing a pendant azadibenzocyclooctyne moiety, were synthesised and a robust methodology was determined to form covalent bonds between them and azide-functionalised trastuzumab, an anti-HER2 mAb, using strain-promoted azide-alkyne cycloaddition. Unlike the DOTA derivative, the NODAGA- and 15-5-mAb conjugates were radiolabelled with 64Cu, obtaining excellent radiochemical yields, under mild conditions. Although all the radioimmunoconjugates showed excellent stability in PBS or mouse serum, [64Cu]Cu-15-5- and [64Cu]Cu-NODAGA-trastuzumab presented higher resistance to transchelation when challenged by EDTA. Finally, the immunoreactive fraction of the radioimmunoconjugates (88–94%) was determined in HER-2 positive BT474 human breast cancer cells, confirming that the bioconjugation and radiolabelling processes implemented had no significant impact on antigen recognition.
科研通智能强力驱动
Strongly Powered by AbleSci AI